Saturday 17 October 2026 Export CBIO’s income statement to Excel — free account

Crescent Biopharma, Inc.

Crescent Biopharma, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.8 million, up 108,340.0% from fiscal 2023. In the quarter to June 2026, revenue grew 1,038,900.0%, EPS grew 85.0% and free cash flow fell 7.04%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

11.84 0.64 −5.13%

Follow CBIO

Alert me

Market cap: $463.6M
P/E: 0.0×
Fwd P/E: −5.6×
Dividend yield: —
F-score: n/a
Altman Z: −0.06
Beneish M: n/a
Dividend safety: n/a

Overview Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	(112.14%)	(176.92%)	(167.75%)	(78.63%)	+8 more TTM periods Free account
ROA Full definition →	(97.08%)	(158.03%)	(111.59%)	(63.33%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(102.34%)	(88.91%)	(76.42%)	(42.38%)
Average Days of Receivables Full definition →	—	0.00	0.00	—
Free Cash Flow per Share Full definition →	(2.35)	(2.33)	(6.95)	(1.47)
Free Cash Flow Full definition →	(71.85)	(70.68)	(72.42)	(24.36)
Capital Expenditures Full definition →	0.83	(1.07)	(0.89)	(0.70)
Other line items
Cash ROIC Full definition →	(21.46%)	(18.95%)	(17.40%)	(9.75%)
Accounts Receivable Turnover Full definition →	—	0.00	0.00	—
Accounts Payable Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	0.00%	11,932.52%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →	0.00%	2,434.58%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →	0.00%	1,328.52%	0.00%	0.00%
Interest Coverage Full definition →	—	—	(39.06)	—
Operating CF/Net income Full definition →	0.44	0.43	0.46	0.49
Depreciation/Fixed assets Full definition →	0.24	0.16	0.10	0.05
Capex/Depreciation Full definition →	3.92	(7.20)	(10.58)	(18.22)
Revenue per Share Full definition →	0.00	0.04	0.00	0.00
Operating CF per Share Full definition →	(2.38)	(2.29)	(6.87)	(1.43)
Capex per Share Full definition →	0.03	(0.04)	(0.09)	(0.04)
Capex to Sales Full definition →	0.00	0.88	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly